Home / Themes / Genomics '25: Synthentic Biology & Biofoundries
Last updated
Theme no thesis · 2/5 sections · Tickers 2 with notes · 10 pending
Bull / Bear Details has the investment thesis and bull/bear points. Overview is monitoring guidance (hiring, forums, second-order trends, search keywords, Google Trends, datasets).
Discussions on new research, technologies, career advice, and community sentiment within synthetic biology. Look for mentions of specific companies, tools, or emerging applications.
Broader biotechnology discussions, funding news, industry trends, and job market insights relevant to synthetic biology and biofoundries.
Discussions on computational tools, data analysis, AI/ML applications in biology, and bioinformatics career trends, which are critical for AI-driven synthetic biology.
Professional discussions, job postings, company announcements, and expert opinions on industry developments and collaborations.
Early-stage innovation, student projects, and emerging talent in synthetic biology. Can indicate future trends and technological directions.
Not in registry
Metric/field Federal Funds Effective Rate (DFF)
Cadence daily
Why it matters Influences the cost of capital for growth-oriented biotechnology companies and impacts investor risk appetite for early-stage assets.
Signal to watch Rising rates increase cost of capital, potentially dampening investment in R&D-heavy firms. Declining rates can stimulate investment.
Confidence: high
Not in registry
Metric/field Total Venture Capital Investment (USD) in Biotechnology & Pharma Sector
Cadence quarterly
Why it matters Indicates the overall health and investor confidence in the biotech sector, crucial for funding the capital-intensive R&D and scaling efforts of synthetic biology companies.
Signal to watch Increasing funding suggests strong investor confidence and capital availability for innovation. Declining funding indicates potential headwinds.
Confidence: high
Not in registry
Metric/field Industrial Production Index: Chemical Products (NAICS 325)
Cadence monthly
Why it matters Many synthetic biology companies are involved in biomanufacturing chemicals, materials, and enzymes. This index reflects the activity and demand in a key end-market.
Signal to watch Rising index suggests increased industrial activity and demand for bio-based chemical products. Declining index indicates slowdown.
Confidence: medium
Matched (medium)lab_headcount · access=api
Metric/field All Employees, Scientific Research and Development Services (NAICS 5417)
Cadence monthly
Why it matters Synthetic biology and biofoundries are highly R&D intensive. Growth in this employment category indicates expansion and investment in the underlying scientific and engineering workforce.
Signal to watch Increasing employment suggests a healthy and expanding R&D ecosystem, crucial for innovation in the theme. Declining employment indicates contraction.
Confidence: medium
Not in registryaccess=api
Metric/field Producer Price Index: Pharmaceutical and Medicine Manufacturing (NAICS 3254)
Cadence monthly
Why it matters Reflects pricing power and cost pressures within the pharmaceutical manufacturing sector, a key end-market for many synthetic biology applications (e.g., biocatalysis, drug production).
Signal to watch Rising PPI could indicate stronger demand or increasing input costs, impacting profitability. Declining PPI could suggest weaker demand or falling input costs.
Confidence: medium
Not in registry
Metric/field Search interest for 'AI drug discovery' (worldwide)
Cadence weekly
Why it matters Indicates public and industry interest in the core technology driving the theme's AI-driven drug discovery aspect.
Signal to watch Rising interest suggests increasing awareness, adoption, and potential for innovation. Declining interest could signal waning enthusiasm.
Confidence: high
Not in registry
Metric/field Search interest for 'Synthetic Biology' (worldwide)
Cadence weekly
Why it matters Direct indicator of general interest and awareness in the overarching theme of synthetic biology.
Signal to watch Rising interest suggests growing scientific, industrial, and public engagement with synthetic biology. Declining interest could signal reduced focus.
Confidence: high
Not in registry
Metric/field Count of active clinical trials with keywords 'synthetic biology' OR 'AI drug design' in intervention/condition
Cadence monthly
Why it matters Tracks the translation of synthetic biology and AI drug design into actual clinical development, indicating pipeline growth and therapeutic application.
Signal to watch Increasing number of trials suggests successful progression from research to clinical stages. Declining number could indicate challenges in translation.
Confidence: medium
Not in registry
Metric/field Number of publications containing 'biofoundry' OR 'automated biology' in title/abstract
Cadence monthly
Why it matters Reflects the academic and research output in key areas of the theme, indicating scientific progress and innovation.
Signal to watch Rising publication count suggests increasing research activity and advancements in the field. Declining count could indicate a slowdown in research.
Confidence: medium
Not in registry
Metric/field Count of published patent applications with keywords 'synthetic biology' OR 'biomanufacturing'
Cadence quarterly
Why it matters Indicates innovation, intellectual property development, and competitive activity within the theme.
Signal to watch Increasing patent applications suggest robust innovation and R&D investment. Declining applications could signal reduced innovation.
Confidence: medium
Matchedlinkup_job_postings · access=file · map_only
Metric/field Number of job postings for 'Generative AI Scientist (Drug Design)' or 'LLM Engineer (Biotech)' roles
Cadence irregular
Why it matters Provides insights into hiring trends for specialized AI/ML roles within biotechnology, indicating investment in talent and R&D capacity.
Signal to watch Rising job postings suggest increased investment in AI capabilities and expansion of R&D teams. Declining postings could indicate a slowdown in hiring.
Confidence: high
Matchedlexisnexis_public_records_identity_business_data · access=file · map_only
Metric/field Count of granted patents related to 'synthetic biology' or 'biofoundry' technologies
Cadence irregular
Why it matters Tracks the successful protection of intellectual property, indicating innovation and competitive positioning of companies within the theme.
Signal to watch Increasing patent grants suggest strong innovation and a growing competitive moat. Declining grants could signal reduced IP protection or innovation.
Confidence: high
Matched (medium)norstella_drug_pipeline_asset_intelligence · access=file · map_only
Metric/field Number of AI-designed biologic drug candidates in preclinical or clinical development phases
Cadence irregular
Why it matters Provides granular tracking of the direct output of AI-driven drug discovery efforts, indicating the success and progression of these platforms.
Signal to watch Increasing number of candidates, especially in later stages, suggests validation of AI platforms and potential for future commercialization. Declining numbers could indicate challenges in drug development.
Confidence: high
Matched (medium)importgenius_customs_import_export_records · access=file · map_only
Metric/field Volume/Value of imports/exports of 'fermentation equipment' or 'bioreactors' by key countries
Cadence irregular
Why it matters Provides insights into the scale-up and investment in biomanufacturing infrastructure globally, relevant for companies involved in industrial biomanufacturing.
Signal to watch Increasing trade volumes suggest expansion of biomanufacturing capacity and activity. Declining volumes could indicate a slowdown in infrastructure build-out.
Confidence: medium
Matchedsimilarweb_website_traffic_engagement · access=file · map_only
Metric/field Total unique visitors and engagement metrics (e.g., bounce rate, pages per session) for top synthetic biology company websites (e.g., Twist Bioscience, Ginkgo Bioworks)
Cadence irregular
Why it matters Provides an indication of market interest, customer engagement, and competitive standing for key players in the theme.
Signal to watch Increasing unique visitors and improved engagement metrics suggest growing interest and potential business activity. Declining metrics could indicate reduced market attention.
Confidence: medium
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type | Catalyst Source |
|---|---|---|---|---|---|---|---|---|---|
| ABSI_1a41c21d | fourth quarter of this year | 2026-10-01 | 2026-12-31 | Initiation of a Phase II clinical trial of ABS-201 for endometriosis. | This expands the clinical development of ABS-201 into another significant multi-billion dollar market, demonstrating the broad potential of the prolactin receptor mechanism and diversifying the pipeline. | Ticker | 2026-08-11 | earnings_transcript | ABSI (ticker) |
| TWST_1d572939 | November | 2026-11-01 | 2026-11-30 | Release full year fiscal 2027 guidance. | This will provide investors with a clearer financial outlook for the upcoming fiscal year, influencing sentiment and valuation. | Ticker | 2026-08-03 | earnings_transcript | TWST (ticker) |
| ABSI_2e685f85 | early next year | 2027-01-01 | 2027-03-31 | Full proof of concept (26-week) data readout for ABS-201 in pattern hair loss. | This data will provide a more robust assessment of ABS-201's efficacy, including hair regrowth, and will be crucial for determining the drug's potential as a 'home run product' in a multi-billion dollar market. | Ticker | 2026-08-11 | earnings_transcript | ABSI (ticker) |
